Tag: Semaglutide

Millions of Americans are eating less, buying fewer groceries and rethinking their relationship with food. But restaurants are discovering something interesting: losing your appetite doesn’t mean losing your taste for a fabulous night out.

I love restaurants. Always have. The dining room, the wine list, the people watching, the pleasure of ordering something I’d never bother making at home. Restaurants aren’t just where I eat. They’re my favorite form of entertainment.

Which is why I’ve been glued to all the predictions about what GLP-1 medications will do to the restaurant industry. Because I’ve had two very different experiences with them.

The first was several years ago, with Ozempic. For six weeks, I was absolutely miserable. The side effects were so bad I barely wanted to eat, let alone go out to dinner. My grocery bills were wonderfully low. My restaurant spending practically vanished. But let’s not confuse being too sick to enjoy a meal with discovering a fabulous new way to save money. That’s not a budget strategy. That’s a stomach flu with a prescription.

More recently, I tried retatrutide for another six weeks. This time my goal was very specific: lose the last ten pounds. Same six weeks. Different medication. Different circumstances. A completely different experience, for me.

I wasn’t trying to erase every thought of food. I wanted a smaller appetite without feeling awful. And that’s how it felt.

I still loved going out. I still wanted the tequila list, the conversation, the candlelight and a beautiful dinner. I just couldn’t eat very much of it. So I started sharing entrées, ordering appetizers instead of mains and drinking a little less.

And that’s when the math got interesting. My grocery bill went down. My restaurant bill? Not nearly as much.

Try ordering two cocktails at a nice restaurant these days. At $25 or $30 apiece, you’ve spent $50 or $60 before a single bite of food arrives. Meanwhile, the popular spots I love are still packed. Reservations haven’t magically gotten easier.

So here’s the question: if millions of Americans are eating less, why isn’t dinner out getting any cheaper? And what happens to an industry built on selling food when its customers still want the experience but don’t necessarily want the calories?

You’re Not Buying Dinner. You’re Renting a Table.

Here’s the thing I think everyone’s predictions got wrong. We’ve been treating appetite as the only reason people spend money on food. As if we go to restaurants because we’re hungry, eat until we’re full and go home.

That’s one way to dine. It’s not the only one.

People go to restaurants for birthdays, anniversaries, business deals, first dates, gossip, celebrations and the occasional evening when they simply cannot face one more conversation about what to cook. Sometimes dinner isn’t the meal. Dinner is the activity.

So think about what you’re actually paying for at a nice restaurant. You’re renting a beautiful room for two hours. You’re renting the people who seat you, pour your wine, cook your fish and clear your plate without making you feel bad about leaving half of it. You’re renting the glassware, the flowers, the music and the lighting that makes everyone look ten years younger.

None of that gets cheaper because you decided to split the fish.

The food is just one line on the invoice. The rest of the bill is rent.

Once you see it that way, it makes sense why eating half as much doesn’t cut the check in half. GLP-1s may be changing our appetites, but they’re not necessarily changing what we love about going out. And judging by the latest restaurant research, that’s becoming an important distinction.

The Grocery Store Is Already Feeling It

The supermarket is where the impact shows up most clearly.

A study published in the Journal of Marketing Research (first online in December 2025, with a title I adore: “The No-Hunger Games”) combined medication data with real household shopping receipts. Within six months of someone in the house starting a GLP-1, grocery spending dropped by an average of 5.3 percent. In higher-income households, it fell 8.2 percent.

Some categories took a much bigger hit. Savory snacks fell 10.1 percent. Spending at fast-food chains, coffee shops and other quick-service spots dropped about 8 percent.

That’s not a few people skipping dessert. That’s a shift big enough to rattle entire food categories. Fewer impulse buys. Fewer chips. Fewer jumbo packages bought with every intention of finishing them. And in some homes, potentially a lot less food going in the trash.

The changes did fade a bit over time, and households that stopped treatment tended to drift back toward their old shopping habits. So we can’t assume the American grocery cart has been permanently transformed. But food companies have a pretty good reason to pay attention.

I can relate to this one. When your appetite shrinks, grocery shopping changes in ways you don’t expect. You don’t need the same amounts. Some things suddenly don’t appeal at all. And a fully stocked fridge becomes a very expensive collection of good intentions.

But here’s where I think the story gets more interesting. The grocery store and the restaurant aren’t really selling the same thing. One sells food to take home. The other is selling you an evening out, and apparently a lot of us still want one.

The Restaurant Numbers Are Surprisingly Upbeat

In May 2026, the National Restaurant Association released research on how GLP-1 users actually behave when they eat out. And the findings were a little more interesting than the restaurant apocalypse some people had predicted.

Eighty-seven percent of GLP-1 users surveyed said they enjoy going to restaurants. Even better, 71 percent called restaurants an essential part of their lifestyle, compared with 61 percent of adults overall.

That’s hardly a crowd preparing to give up dining out.

There was a catch, though. Nearly half of GLP-1 users said they eat out less often since starting treatment. About a quarter said they go more, and roughly three in ten said not much had changed.

So yes, some restaurants may be losing visits, and that’s important. But the people who are still going out are also changing what they order. Smaller portions, more protein, more vegetables and fewer indulgent dishes are all part of the picture.

In other words, restaurants aren’t necessarily losing the customer altogether. Sometimes they’re just losing part of the order. And that’s a very different business problem.

What If the Appetizer Becomes the Main Event?

I’ve noticed this in my own dining habits. A full entrée can feel like an unreasonable commitment. Not because it isn’t delicious, but because halfway through, I’m done. And I don’t love paying for a gorgeous dish just to watch most of it leave the table.

So appetizers start looking better. Sharing looks better. A few perfect bites can be far more satisfying than a mountain of food.

Now picture that preference spreading across millions of diners.

For decades, American restaurants have competed on abundance. Huge portions. Generous sides. Enough food for tomorrow’s lunch. But what if the next wave of diners doesn’t want abundance? What if they’d rather have something smaller, more interesting and beautifully made?

That sounds like great news for places that already do small plates, tapas and tasting menus. Personally, I love the idea of ordering a few things I actually want instead of committing to an enormous entrée simply because that’s how the menu is organized.

But there’s a catch. Customers may want smaller portions without wanting a smaller experience. And remember the rent. Restaurants are still paying for the staff, the kitchen, the lease and everything else that comes with running the place. Putting less food on a plate doesn’t necessarily make the meal much cheaper to serve.

So the great GLP-1 restaurant revolution could turn out to be wonderfully ironic. Less food. Pretty much the same bill. And, if we’re lucky, a more thoughtful experience.

Restaurants Are Already Experimenting

This isn’t hypothetical. In 2025, Cuba Libre Restaurant & Rum Bar rolled out a smaller-portion menu designed for customers on GLP-1 medications, with lighter dishes and more protein and fiber. By 2026, some of those dishes were being tested on the regular menu.

Big chains are paying attention too. Chipotle has leaned harder into high-protein options, and other restaurants have been exploring smaller portions and more flexible ways to order.

Of course, not every smaller menu item is about GLP-1s. Restaurant prices have climbed, and plenty of people who’ve never touched an appetite medication would happily order a smaller entrée if it cost less. I certainly don’t think you need to be on Ozempic to wonder why a salad now costs more than lunch used to.

That’s what makes this moment so interesting. Several things are happening at once. Diners are more price-conscious, some are eating less, others want more protein, and plenty simply don’t want to pay $38 for a plate they’ll never finish.

My guess? Smaller portions are part health trend, part affordability play and possibly part of a longer-term change in how we eat. But the real question for diners is whether smaller plates will actually mean smaller bills. Because a smaller portion at almost the same price isn’t the bargain anyone was hoping for.

The Cocktail Problem Nobody Talks About

Then there’s the bar.

During my more recent GLP-1 experience, I found myself drinking less. Not swearing off martinis. Just wanting less. And as a woman who once considered champagne its own food group, that’s saying something.

There’s some interesting research emerging here, too. In 2025, a small randomized trial in JAMA Psychiatry studied semaglutide in 48 people with alcohol use disorder. Compared with placebo, participants showed reductions in certain measures of drinking and alcohol cravings. It’s early research, and it doesn’t mean every GLP-1 medication will have the same effect on everyone, but I find it fascinating that these compounds may be influencing more than what we want for dinner.

For restaurants, that’s a pretty big deal because drinks have traditionally been among the more profitable things on the menu. If someone who used to order three cocktails now orders one, the restaurant could lose some of its best-margin revenue.

The customer should theoretically save money, too. Except have you seen cocktail prices lately?

At some upscale spots, one drink runs $25 or $30. Add tax and tip, and you can spend an impressive amount on something you finish in fifteen minutes. Fewer drinks help, sure, but when the price per glass keeps climbing, the savings feel a lot less dramatic than the change in your drinking. And if you switch to a fancy zero-proof cocktail, don’t be surprised when it costs almost as much.

Which leaves restaurants with an interesting problem. If customers are drinking less alcohol, will they make up the difference with sophisticated nonalcoholic drinks, better food or an experience people are happy to pay more for? Or will they have to accept that some customers simply aren’t spending what they used to?

I suspect we’ll see a little of both.

Not Every GLP-1 Experience Is the Same

One thing I’ve noticed about the whole GLP-1 conversation is that people tend to throw all these medications into one big category, as though they’re basically interchangeable. But there’s quite a bit more going on, and I think the peptide community is having a more interesting conversation about it than most people realize.

My first six weeks on Ozempic were awful. I was so sick that eating wasn’t even appealing, which is one way to lose weight, I suppose, but certainly not one I’d recommend. When I tried retatrutide more recently, also for six weeks, it was a completely different experience. Granted, I was at a different point in my life and only looking to lose the last ten pounds, but I could still enjoy restaurants, have a glass of wine and look forward to dinner. I simply got full much sooner.

And to me, that’s a pretty big difference. I don’t want to spend my life avoiding food. I happen to like food. A lot. I’d just rather not spend the entire afternoon thinking about what I’m going to eat next.

What’s interesting is how differently these compounds work. Ozempic, or semaglutide, targets the GLP-1 receptor. Tirzepatide works on two receptors, GLP-1 and GIP. And retatrutide, which is still being studied and isn’t FDA-approved, targets three: GLP-1, GIP and glucagon. That’s where the whole “triple G” nickname comes from. It doesn’t mean three receptors are automatically better than one, but I find it fascinating how much the science has evolved in a relatively short time.

There’s also a shift happening in peptide circles that I think deserves more attention. Not everyone is chasing the highest dose or trying to make food completely unappealing. I’m seeing more conversations about using smaller amounts and finding that sweet spot where you’re satisfied sooner, without feeling like your appetite has been switched off entirely.

Some people call it microdosing, although there isn’t an established clinical protocol behind that term yet. I think the interesting part is less about the label and more about the thinking behind it. Why would we automatically assume stronger appetite suppression is always better? If someone can comfortably eat less, enjoy their meals and go about their normal life, isn’t that a pretty appealing goal?

Of course, my experience doesn’t mean retatrutide will feel better for everyone. These medications can all cause side effects, and the research on lower-dose approaches is still developing. But I do think we’re moving toward a more interesting conversation about appetite, where the goal isn’t necessarily to make people stop wanting food altogether.

Which brings me back to restaurants. If you’re too nauseated to eat, you’re probably not booking dinner reservations. But if you’re simply happy with an appetizer and a couple of bites of someone else’s entrée, why wouldn’t you still go out?

That’s the difference I think restaurants need to pay attention to. People may want less food without wanting less of the experience.

Food Noise Isn’t the Same as Loving Food

One of the best phrases to come out of the GLP-1 era is “food noise.” It’s that constant mental chatter about food. What should I eat? What’s in the fridge? Should I order something? When do I get to eat again?

For a lot of people, turning that volume down feels like freedom. And researchers are studying how those food-related thoughts change for people taking semaglutide.

But here’s where I think we sometimes get the conversation wrong. Constantly thinking about food and genuinely loving it are not the same thing.

I don’t need to spend all afternoon obsessing about dinner to appreciate an extraordinary meal. I don’t need a huge appetite to enjoy a beautiful appetizer. And I definitely don’t need to clean my plate to enjoy the people sitting across the table.

One of the more surprising parts of my recent experience was realizing how little of my love for restaurants actually had to do with how much food I ate. I still wanted to go, I still enjoyed the entire production, and I still looked forward to the evening. I just ordered differently.

That may be one of the most important things for the restaurant industry to understand. Some customers are mainly buying food. Others are buying an evening. And plenty of us are buying a bit of both.

Fast Food May Have a Bigger Problem Than Fine Dining

Here’s where it gets really interesting. Different corners of the restaurant world may feel the effects of GLP-1s very differently.

That household shopping study found about an 8 percent drop in spending at fast-food chains, coffee shops and other quick-service spots. A separate 2026 survey of 300 GLP-1 users from investment firm William Blair also pointed to substantial reductions in fast-food visits. Other industry research found that some people kept going out about as often but simply ordered differently.

These studies used different groups and methods, so we shouldn’t assume they all tell exactly the same story. But together, they suggest something worth watching.

If your appetite is smaller and you’re snacking less, it’s easy to skip the drive-through. Maybe you don’t feel like stopping for fries on the way home, or picking up something because you suddenly got hungry at three in the afternoon.

But a dinner reservation at a beautiful restaurant is a different kind of decision. There’s an occasion, people you want to see, a plan for the evening and maybe even an outfit involved. You don’t need to be starving to want any of that.

Now, I don’t think fine dining is somehow immune to changing appetites. People who share plates or skip drinks can still spend less, and expensive restaurants have plenty of challenges that have nothing to do with GLP-1s.

But I do wonder whether restaurants that are really good at atmosphere, service and creating an experience will be better positioned than businesses that rely heavily on selling large quantities of food.

When appetite matters less, the experience may matter more.

And as someone who considers restaurants a hobby, I find that possibility pretty interesting.

So, Are We About to Pay More for Less?

I can picture a restaurant world that adapts beautifully to smaller appetites. More interesting appetizer menus, smaller and thoughtfully composed plates, flexible tasting options, better nonalcoholic drinks and less waste. The freedom to order exactly what you want instead of committing to an enormous entrée sounds pretty wonderful to me.

I can also picture something less wonderful.

Smaller portions with barely smaller prices. A premium charge for the “GLP-1-friendly” menu. Protein powder sneaking into everything whether you want it or not. And one more opportunity for an industry to charge more for something that got smaller.

Snack companies have a word for that: shrinkflation. Restaurants may be about to discover their own version.

I don’t think every restaurant needs to reinvent its menu because some customers are taking appetite medications. But I do think there’s an opportunity here for restaurants that understand people may want less food without wanting a lesser experience.

And from the customer’s side, it pays to notice what you’re actually getting. A smaller portion isn’t automatically a better deal, just as a giant portion isn’t automatically good value if half of it ends up in the trash.

Every meal doesn’t need to become a carefully calculated medical event. Sometimes you just want a wonderful dinner.

And if restaurants can give us that with less waste, more flexibility and food we’re genuinely excited to eat, I’d call that progress.

The winners may not be the restaurants that give us the most food. They may be the ones that understand exactly what makes an evening worth paying for.

Do This Week

1. Look at what you actually spend on food.

Separate groceries, takeout, restaurants and alcohol. You may find that eating less has changed some categories far more than others.

2. Notice what you’re really paying for.

Next time you go out, think about what made the night worth it. Was it the amount of food, or the room, the people and the evening itself?

3. Don’t confuse feeling sick with successful appetite management.

If a medication makes eating or drinking difficult because of nausea or other side effects, talk to a qualified healthcare professional. Feeling terrible isn’t a financial strategy, and it shouldn’t be the goal.

4. Give the appetizer menu another look.

Smaller dishes, half portions and shareable plates can make going out more enjoyable when you’re not particularly hungry. Just check the prices before assuming you’re getting a deal.

5. Watch what you’re spending on drinks.

Whether you’re drinking less alcohol or trying zero-proof cocktails, take a look at the beverage portion of your bill. It may surprise you how much of the evening’s cost is sitting in those glasses.

6. Make the food you do eat count.

If your appetite is much smaller, it’s worth paying attention to protein, fiber, fluids and the other nutrients your body still needs. Feeling full sooner doesn’t mean those needs disappear.

7. Keep enjoying food.

A smaller appetite doesn’t have to mean a smaller social life. Food can still be delicious, restaurants can still be wonderful, and a night out can still be worth getting dressed up for.

---

September Wellness publishes independent educational commentary, not medical or financial advice. Personal experiences with peptides and GLP-1 medications are not clinical evidence or treatment recommendations. Retatrutide remains investigational and is not FDA-approved. Lower-dose and microdosing approaches discussed in peptide communities have not been established as safe or effective protocols. Consult a qualified healthcare professional about medication decisions and side effects.

Sources & Further Reading

1. Hristakeva, S., Liaukonytė, J., and Feler, L. The No-Hunger Games: How GLP-1 Medication Adoption Is Changing Consumer Food Demand. Journal of Marketing Research, 2026; first published online December 2025. Household transaction data showing changes in grocery, snack and limited-service restaurant spending after GLP-1 adoption.

2. National Restaurant Association. GLP-1 and Restaurants: Shifting Habits, Not Shrinking Demand. May 2026. Examines how GLP-1 users dine out, what they order and how much they continue to value restaurants.

3. Circana. GLP-1 Users Aren’t Ditching Restaurants, But Their Ordering Habits Are Changing. January 2026. Consumer research examining how restaurant visits and orders change during GLP-1 treatment.

4. PwC. The End of More: How GLP-1 Users Shop, Eat, and Seek Support. June 2026. Investigates the broader consumer-spending effects of GLP-1 use, including groceries, beverages and other purchasing habits.

5. Noble, A. Smaller Portions, Protein Everything: How GLP-1s Are Changing Restaurant Menus. Vogue, April 2026. Reports on restaurants offering smaller portions, protein-focused dishes and more flexible menus.

6. Yu, A. Can Philadelphia Restaurants Reduce Overeating by Offering Small Portions?. WHYY, May 2026. Examines restaurant portion-size experiments, including Cuba Libre’s smaller-portion menu.

7. Hendershot, C. S., et al. Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry, 2025. An early randomized trial examining how semaglutide may affect alcohol cravings and consumption.

8. Arnaut, T., et al. Retrospective Assessment of Food Noise Changes After Initiation of Injectable Semaglutide for Weight Management in the USA: The INFORM Survey. Advances in Therapy, 2026. Explores self-reported changes in food-related thoughts among people using semaglutide.

9. William Blair. Why Quick-Service Restaurants Are Most Impacted by GLP-1 Usage. September 2026. Discusses a survey of 300 GLP-1 users and what their reported spending habits might mean for fast-food businesses.

10. Eli Lilly and Company. What to Know About Retatrutide. Updated October 2026. Explains retatrutide’s three-receptor mechanism, investigational status and ongoing clinical development.